N/A
N=11
Investigating Brown Adipose Tissue Activation in Humans
Metabolic Diseases
Bottom Line
View on ClinicalTrials.gov: NCT01935791 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Brown Adipose Tissue Activation Following Glucagon or Saline Infusion — 0.074; 0.010; 0.029 MR[gluc] umol/kg/min — p=<0.01
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Period 1 Visit 1 - Cold PET-CT Vehicle, Visit 2 -Warm PET-CT Vehicle (Other); Period 1 Visit 1 - Cold PET-CT Vehicle, Visit 2 -Warm PET-CT Glucagon (Drug); Period 1 Visit 1 - Cold PET-CT Vehicle, no visit 2 as BAT negative (Other); Period 2 - Visit 1 Warm Control vehicle, Visit 2 Warm Glucagon, Visit 3 Cold control (Drug); Period 2 - Visit 1 Warm Glucagon, Visit 2 Cold control , Visit 3 Warm control (Drug); Period 2 -Visit 1 cold control, Visit 2 warm control, Visit 3 Warm glucagon (Drug); Period 2 -Visit 1 cold control, visit 2 warm glucagon, visit 3 warm control (Drug); Period 2- Visit 1 Warm glucagon, visit 2 warm control, visit 3 cold control (Drug); Period 2 - Visit 1 Warm control, visit 2 cold control, visit 3 warm glucagon (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Nov 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Brown Adipose Tissue Activation Following Glucagon or Saline Infusion |
0.074; 0.010; 0.029 | <0.01 sig |
| PRIMARY Increase in Energy Expenditure Following Glucagon or Saline Infusion |
193.0; 41.1; 230.8 | <0.001 sig |
Summary
The purpose of this study is to determine what can activate brown adipose tissue (BAT).
Eligibility Criteria
Inclusion Criteria
- aged >18 years
Exclusion Criteria
- medical conditions
- recreational drug use
- participation in other trials within the preceding 2 months
- blood donation within 3 months of study participation
Data sourced from ClinicalTrials.gov (NCT01935791). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.